{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:57:59Z","timestamp":1788793079304,"version":"build-2803163510"},"reference-count":79,"publisher":"Tohoku University Medical Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2024.j116","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T22:11:20Z","timestamp":1730931080000},"page":"145-152","source":"Crossref","is-referenced-by-count":2,"title":["The Potential of CAR-T cells for Treating Heart Diseases: Current Status and Hurdles in Clinical Translation"],"prefix":"10.1620","volume":"266","author":[{"given":"Ruxia","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganggang","family":"Si","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sancong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Jincheng People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abdalla, A.M.E., Miao, Y., Ahmed, A.I.M., Meng, N. &amp; Ouyang, C.(2024) CAR-T cell therapeutic avenue for fighting cardiac fibrosis: Roadblocks and perspectives. <i>Cell Biochem. Funct.<\/i>, 42, e3955.","DOI":"10.1002\/cbf.3955"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Acevedo-Whitehouse, K. &amp; Bruno, R.(2023) Potential health risks of mRNA-based vaccine therapy: A hypothesis. <i>Med. Hypotheses<\/i>, 171, 111015.","DOI":"10.1016\/j.mehy.2023.111015"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Aghajanian, H., Kimura, T., Rurik, J.G., Hancock, A.S., Leibowitz, M.S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., Wang, T., Bedi, K., Morley, M.P., Linares Saldana, R.A., Bolar, N.A.,  et al. (2019) Targeting cardiac fibrosis with engineered T cells. <i>Nature<\/i>, 573, 430-433.","DOI":"10.1038\/s41586-019-1546-z"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Alnefaie, A., Albogami, S., Asiri, Y., Ahmad, T., Alotaibi, S.S., Al-Sanea, M.M. &amp; Althobaiti, H.(2022) Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions. <i>Front. Bioeng. Biotechnol.<\/i>, 10, 797440.","DOI":"10.3389\/fbioe.2022.797440"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Ba, H., Dai, Z., Zhang, Z., Zhang, P., Yin, B., Wang, J., Li, Z. &amp; Zhou, X.(2023) Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers. <i>J. Immunother. Cancer<\/i>, 11, e003837.","DOI":"10.1136\/jitc-2021-003837"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Besse, S., Nadaud, S., Balse, E. &amp; Pavoine, C.(2022) Early Protective Role of Inflammation in Cardiac Remodeling and Heart Failure: Focus on TNFalpha and Resident Macrophages. <i>Cells<\/i>, 11, 1249.","DOI":"10.3390\/cells11071249"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Bradshaw, A.D. &amp; DeLeon-Pennell, K.Y.(2020) T-cell regulation of fibroblasts and cardiac fibrosis. <i>Matrix Biol.<\/i>, 91-92, 167-175.","DOI":"10.1016\/j.matbio.2020.04.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Brudno, J.N. &amp; Kochenderfer, J.N.(2016) Toxicities of chimeric antigen receptor T cells: recognition and management. <i>Blood<\/i>, 127, 3321-3330.","DOI":"10.1182\/blood-2016-04-703751"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Bughda, R., Dimou, P., D\u2019Souza, R.R. &amp; Klampatsa, A.(2021) Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma. <i>Immunotargets Ther.<\/i>, 10, 313-323.","DOI":"10.2147\/ITT.S291767"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Campillo-Davo, D., De Laere, M., Roex, G., Versteven, M., Flumens, D., Berneman, Z.N., Van Tendeloo, V.F.I., Anguille, S. &amp; Lion, E.(2021) The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy. <i>Pharmaceutics<\/i>, 13, 396.","DOI":"10.3390\/pharmaceutics13030396"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Catal\u00e1n, D., Mansilla, M.A., Ferrier, A., Soto, L., Oleinika, K., Aguillon, J.C. &amp; Aravena, O.(2021) Immunosuppressive Mechanisms of Regulatory B Cells. <i>Front. Immunol.<\/i>, 12, 611795.","DOI":"10.3389\/fimmu.2021.611795"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Chmielewski, M., Hombach, A.A. &amp; Abken, H.(2013) Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T Cells. <i>Front. Immunol.<\/i>, 4, 371.","DOI":"10.3389\/fimmu.2013.00371"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Couzin-Frankel, J. (2013) Breakthrough of the year 2013. Cancer immunotherapy. <i>Science<\/i>, 342, 1432-1433.","DOI":"10.1126\/science.342.6165.1432"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Dabiri, H., Safarzadeh Kozani, P., Habibi Anbouhi, M., Mirzaee Godarzee, M., Haddadi, M.H., Basiri, M., Ziaei, V., Sadeghizadeh, M. &amp; Hajizadeh Saffar, E.(2023) Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies. <i>Biomark. Res.<\/i>, 11, 67.","DOI":"10.1186\/s40364-023-00509-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Dalal, P.J., Patel, N.P., Feinstein, M.J. &amp; Akhter, N.(2022) Adverse Cardiac Effects of CAR T-Cell Therapy: Characteristics, Surveillance, Management, and Future Research Directions. <i>Technol. Cancer Res. Treat.<\/i>, 21, 15330338221132927.","DOI":"10.1177\/15330338221132927"},{"key":"16","doi-asserted-by":"crossref","unstructured":"De Marco, R.C., Monzo, H.J. &amp; Ojala, P.M.(2023) CAR T Cell Therapy: A Versatile Living Drug. <i>Int. J. Mol. Sci.<\/i>, 24, 6300.","DOI":"10.3390\/ijms24076300"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Drescher, H.K., Bartsch, L.M., Weiskirchen, S. &amp; Weiskirchen, R.(2020) Intrahepatic T(H)17\/T(Reg) Cells in Homeostasis and Disease-It\u2019s All About the Balance. <i>Front. Pharmacol.<\/i>, 11, 588436.","DOI":"10.3389\/fphar.2020.588436"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Feng, Q., Li, Q., Zhou, H., Sun, L., Lin, C., Jin, Y., Wang, D. &amp; Guo, G.(2022) The role of major immune cells in myocardial infarction. <i>Front. Immunol.<\/i>, 13, 1084460.","DOI":"10.3389\/fimmu.2022.1084460"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Fine, N.M., Davis, M.K., Anderson, K., Delgado, D.H., Giraldeau, G., Kitchlu, A., Massie, R., Narayan, J., Swiggum, E., Venner, C.P., Ducharme, A., Galant, N.J., Hahn, C., Howlett, J.G., Mielniczuk, L.,  et al. (2020) Canadian Cardiovascular Society\/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis. <i>Can. J. Cardiol.<\/i>, 36, 322-334.","DOI":"10.1016\/j.cjca.2019.12.034"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Frangogiannis, N.G.(2014) The inflammatory response in myocardial injury, repair, and remodelling. <i>Nat. Rev. Cardiol.<\/i>, 11, 255-265.","DOI":"10.1038\/nrcardio.2014.28"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Fujiwara, K., Tsunei, A., Kusabuka, H., Ogaki, E., Tachibana, M. &amp; Okada, N.(2020) Hinge and Transmembrane Domains of Chimeric Antigen Receptor Regulate Receptor Expression and Signaling Threshold. <i>Cells<\/i>, 9, 1182.","DOI":"10.3390\/cells9051182"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Gaidai, O., Cao, Y. &amp; Loginov, S.(2023) Global Cardiovascular Diseases Death Rate Prediction. <i>Curr. Probl. Cardiol.<\/i>, 48, 101622.","DOI":"10.1016\/j.cpcardiol.2023.101622"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Rivas, G., Castillo, E.C., Gonzalez-Gil, A.M., Maravillas-Montero, J.L., Brunck, M., Torres-Quintanilla, A., Elizondo-Montemayor, L. &amp; Torre-Amione, G.(2020) The role of B cells in heart failure and implications for future immunomodulatory treatment strategies. <i>ESC Heart Fail.<\/i>, 7, 1387-1399.","DOI":"10.1002\/ehf2.12744"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Halade, G.V. &amp; Lee, D.H.(2022) Inflammation and resolution signaling in cardiac repair and heart failure. <i>EBioMedicine<\/i>, 79, 103992.","DOI":"10.1016\/j.ebiom.2022.103992"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Hanssens, H., Meeus, F., De Veirman, K., Breckpot, K. &amp; Devoogdt, N.(2022) The antigen-binding moiety in the driver\u2019s seat of CARs. <i>Med. Res. Rev.<\/i>, 42, 306-342.","DOI":"10.1002\/med.21818"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Ja\u00e9n, R.I., Val-Blasco, A., Prieto, P., Gil-Fern\u00e1ndez, M., Smani, T., L\u00f3pez-Send\u00f3n, J.L., Delgado, C., Bosc\u00e1, L. &amp; Fern\u00e1ndez-Velasco, M.(2020) Innate Immune Receptors, Key Actors in Cardiovascular Diseases. <i>JACC Basic Transl. Sci.<\/i>, 5, 735-749.","DOI":"10.1016\/j.jacbts.2020.03.015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Jayaraman, J., Mellody, M.P., Hou, A.J., Desai, R.P., Fung, A.W., Pham, A.H.T., Chen, Y.Y. &amp; Zhao, W.(2020) CAR-T design: Elements and their synergistic function. <i>EBioMedicine<\/i>, 58, 102931.","DOI":"10.1016\/j.ebiom.2020.102931"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Jyotsna, F., Ikram, J., Nageeta, F., Komal, F., Anjlee, F., Patel, H., Nassri, T., Kumari, M., Kumar, R., Shah, S.U., Kashif, M., Varrassi, G., Kumar, S. &amp; Patel, T.(2023) Unlocking the Potential of Immunotherapy in Cardiovascular Disease: A Comprehensive Review of Applications and Future Directions. <i>Cureus<\/i>, 15, e42790.","DOI":"10.7759\/cureus.42790"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Khawar, M.B., Afzal, A., Si, Y. &amp; Sun, H.(2024) Steering the course of CAR T cell therapy with lipid nanoparticles. <i>J. Nanobiotechnology<\/i>, 22, 380.","DOI":"10.1186\/s12951-024-02630-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Khawar, M.B. &amp; Sun, H.(2021) CAR-NK Cells: From Natural Basis to Design for Kill. <i>Front. Immunol.<\/i>, 12, 707542.","DOI":"10.3389\/fimmu.2021.707542"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Kitte, R., Rabel, M., Geczy, R., Park, S., Fricke, S., Koehl, U. &amp; Tretbar, U.S.(2023) Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering. <i>Mol. Ther. Methods Clin. Dev.<\/i>, 31, 101139.","DOI":"10.1016\/j.omtm.2023.101139"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Kucuksezer, U.C., Aktas Cetin, E., Esen, F., Tahrali, I., Akdeniz, N., Gelmez, M.Y. &amp; Deniz, G.(2021) The Role of Natural Killer Cells in Autoimmune Diseases. <i>Front. Immunol.<\/i>, 12, 622306.","DOI":"10.3389\/fimmu.2021.622306"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Labb\u00e9, R.P., Vessillier, S. &amp; Rafiq, Q.A.(2021) Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives. <i>Viruses<\/i>, 13, 1528.","DOI":"10.3390\/v13081528"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Lei, H., Schmidt-Bleek, K., Dienelt, A., Reinke, P. &amp; Volk, H.D.(2015) Regulatory T cell-mediated anti-inflammatory effects promote successful tissue repair in both indirect and direct manners. <i>Front. Pharmacol.<\/i>, 6, 184.","DOI":"10.3389\/fphar.2015.00184"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Li, D. &amp; Wu, M.(2021) Pattern recognition receptors in health and diseases. <i>Signal Transduct. Target Ther.<\/i>, 6, 291.","DOI":"10.1038\/s41392-021-00687-0"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Li, H., Peng, K., Yang, K., Ma, W., Qi, S., Yu, X., He, J., Lin, X. &amp; Yu, G.(2022) Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies. <i>Theranostics<\/i>, 12, 6422-6436.","DOI":"10.7150\/thno.77350"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Li, N., Quan, A., Li, D., Pan, J., Ren, H., Hoeltzel, G., de Val, N., Ashworth, D., Ni, W., Zhou, J., Mackay, S., Hewitt, S.M., Cachau, R. &amp; Ho, M.(2023) The IgG4 hinge with CD28 transmembrane domain improves V(H)H-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer. <i>Nat. Commun.<\/i>, 14, 1986.","DOI":"10.1038\/s41467-023-37616-4"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Liu, J., Liu, F., Liang, T., Zhou, Y., Su, X., Li, X., Zeng, J., Qu, P., Wang, Y., Chen, F., Lei, Q., Li, G. &amp; Cheng, P.(2024) The roles of Th cells in myocardial infarction. <i>Cell Death Discov.<\/i>, 10, 287.","DOI":"10.1038\/s41420-024-02064-6"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Liu, M., Lopez de Juan Abad, B. &amp; Cheng, K.(2021) Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies. <i>Adv. Drug Deliv. Rev.<\/i>, 173, 504-519.","DOI":"10.1016\/j.addr.2021.03.021"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Lu, Y., Xia, N. &amp; Cheng, X.(2021) Regulatory T Cells in Chronic Heart Failure. <i>Front. Immunol.<\/i>, 12, 732794.","DOI":"10.3389\/fimmu.2021.732794"},{"key":"41","doi-asserted-by":"crossref","unstructured":"McCue, A.C., Yao, Z. &amp; Kuhlman, B.(2022) Advances in modular control of CAR-T therapy with adapter-mediated CARs. <i>Adv. Drug Deliv. Rev.<\/i>, 187, 114358.","DOI":"10.1016\/j.addr.2022.114358"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Michels, K.R., Sheih, A., Hernandez, S.A., Brandes, A.H., Parrilla, D., Irwin, B., Perez, A.M., Ting, H.A., Nicolai, C.J., Gervascio, T., Shin, S., Pankau, M.D., Muhonen, M., Freeman, J., Gould, S.,  et al. (2023) Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering. <i>J. Immunother. Cancer.<\/i>, 11, e006292.","DOI":"10.1136\/jitc-2022-006292"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Miller, A.J. &amp; Arnold, A.C.(2019) The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. <i>Clin. Auton. Res.<\/i>, 29, 231-243.","DOI":"10.1007\/s10286-018-0572-5"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Mitra, A., Barua, A., Huang, L., Ganguly, S., Feng, Q. &amp; He, B.(2023) From bench to bedside: the history and progress of CAR T cell therapy. <i>Front. Immunol.<\/i>, 14, 1188049.","DOI":"10.3389\/fimmu.2023.1188049"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Moreno-Cortes, E., Franco-Fuquen, P., Garcia-Robledo, J.E., Forero, J., Booth, N. &amp; Castro, J.E.(2023) ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype. <i>Front. Oncol.<\/i>, 13, 1200914.","DOI":"10.3389\/fonc.2023.1200914"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Morfino, P., Aimo, A., Castiglione, V., Galvez-Monton, C., Emdin, M. &amp; Bayes-Genis, A.(2023) Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy. <i>Heart Fail. Rev.<\/i>, 28, 555-569.","DOI":"10.1007\/s10741-022-10279-x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Muller, Y.D., Nguyen, D.P., Ferreira, L.M.R., Ho, P., Raffin, C., Valencia, R.V.B., Congrave-Wilson, Z., Roth, T.L., Eyquem, J., Van Gool, F., Marson, A., Perez, L., Wells, J.A., Bluestone, J.A. &amp; Tang, Q.(2021) The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28. <i>Front. Immunol.<\/i>, 12, 639818.","DOI":"10.3389\/fimmu.2021.639818"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-L\u00f3pez, P., Ribas-Aparicio, R.M., Becerra-B\u00e1ez, E.I., Fraga-Perez, K., Flores-Martinez, L.F., Mateos-Ch\u00e1vez, A.A. &amp; Luria-P\u00e9rez, R.(2022) Single-Chain Fragment Variable: Recent Progress in Cancer Diagnosis and Therapy. <i>Cancers<\/i> (<i>Basel<\/i>), 14, 4206.","DOI":"10.3390\/cancers14174206"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Norlander, A.E., Madhur, M.S. &amp; Harrison, D.G.(2018) The immunology of hypertension. <i>J. Exp. Med.<\/i>, 215, 21-33.","DOI":"10.1084\/jem.20171773"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Ongun, M., Lokras, A. G., Foged, C.  &amp; Thakur, A. (2022) Lipid nanoparticle-mediated delivery of therapeutic and prophylactic mRNA: Immune activation by ionizable cationic lipids. In <i>RNA Technologies<\/i>, Springer International Publishing, pp. 237-255.https:\/\/doi.org\/10.1007\/978-3-031-08415-7_11.","DOI":"10.1007\/978-3-031-08415-7_11"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Papamichail, A., Kourek, C., Briasoulis, A., Xanthopoulos, A., Tsougos, E., Farmakis, D. &amp; Paraskevaidis, I.(2023) Targeting Key Inflammatory Mechanisms Underlying Heart Failure: A Comprehensive Review. <i>Int. J. Mol. Sci.<\/i>, 25, 510.","DOI":"10.3390\/ijms25010510"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Passaro, A.P., Lebos, A.L., Yao, Y. &amp; Stice, S.L.(2021) Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk. <i>Front. Immunol.<\/i>, 12, 676621.","DOI":"10.3389\/fimmu.2021.676621"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Pongratz, G. &amp; Straub, R.H.(2014) The sympathetic nervous response in inflammation. <i>Arthritis Res. Ther.<\/i>, 16, 504.","DOI":"10.1186\/s13075-014-0504-2"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Qin, V.M., D\u2019Souza, C., Neeson, P.J. &amp; Zhu, J.J.(2021) Chimeric Antigen Receptor beyond CAR-T Cells. <i>Cancers<\/i> (<i>Basel<\/i>), 13, 404.","DOI":"10.3390\/cancers13030404"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Rafiq, S., Hackett, C.S. &amp; Brentjens, R.J.(2020) Engineering strategies to overcome the current roadblocks in CAR T cell therapy. <i>Nat. Rev. Clin. Oncol.<\/i>, 17, 147-167.","DOI":"10.1038\/s41571-019-0297-y"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Chac\u00f3n, A., Betriu-M\u00e9ndez, S., Bartol\u00f3-Ibars, A., Gonz\u00e1lez, A., Mart\u00ed, M. &amp; Juan, M.(2022) Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments. <i>Front. Immunol.<\/i>, 13, 932559.","DOI":"10.3389\/fimmu.2022.932559"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Ravaud, C., Ved, N., Jackson, D.G., Vieira, J.M. &amp; Riley, P.R.(2021) Lymphatic Clearance of Immune Cells in Cardiovascular Disease. <i>Cells<\/i>, 10, 2594.","DOI":"10.3390\/cells10102594"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Reid, D.W., Chen, Q., Tay, A.S., Shenolikar, S. &amp; Nicchitta, C.V.(2014) The unfolded protein response triggers selective mRNA release from the endoplasmic reticulum. <i>Cell<\/i>, 158, 1362-1374.","DOI":"10.1016\/j.cell.2014.08.012"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Rossi, M. &amp; Breman, E.(2024) Engineering strategies to safely drive CAR T-cells into the future. <i>Front. Immunol.<\/i>, 15, 1411393.","DOI":"10.3389\/fimmu.2024.1411393"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Rurik, J.G., Tombacz, I., Yadegari, A., Mendez Fernandez, P.O., Shewale, S.V., Li, L., Kimura, T., Soliman, O.Y., Papp, T.E., Tam, Y.K., Mui, B.L., Albelda, S.M., Pure, E., June, C.H., Aghajanian, H.,  et al. (2022) CAR T cells produced in vivo to treat cardiac injury. <i>Science<\/i>, 375, 91-96.","DOI":"10.1126\/science.abm0594"},{"key":"61","doi-asserted-by":"crossref","unstructured":"Saheera, S. &amp; Krishnamurthy, P.(2020) Cardiovascular Changes Associated with Hypertensive Heart Disease and Aging. <i>Cell Transplant.<\/i>, 29, 963689720920830.","DOI":"10.1177\/0963689720920830"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Satou, R., Penrose, H. &amp; Navar, L.G.(2018) Inflammation as a Regulator of the Renin-Angiotensin System and Blood Pressure. <i>Curr. Hypertens. Rep.<\/i>, 20, 100.","DOI":"10.1007\/s11906-018-0900-0"},{"key":"63","doi-asserted-by":"crossref","unstructured":"Sievers, N.M., Dorrie, J. &amp; Schaft, N.(2020) CARs: Beyond T Cells and T Cell-Derived Signaling Domains. <i>Int. J. Mol. Sci.<\/i>, 21, 3525.","DOI":"10.3390\/ijms21103525"},{"key":"64","doi-asserted-by":"crossref","unstructured":"\u015aled\u017a, M., Wojciechowska, A., Zago\u017cd\u017con, R. &amp; Kaleta, B.(2023) In Situ Programming of CAR-T Cells: A Pressing Need in Modern Immunotherapy. <i>Arch. Immunol. Ther. Exp.<\/i> (<i>Warsz<\/i>), 71, 18.","DOI":"10.1007\/s00005-023-00683-y"},{"key":"65","doi-asserted-by":"crossref","unstructured":"Smirnov, S., Mateikovich, P., Samochernykh, K. &amp; Shlyakhto, E.(2024) Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic. <i>Front. Immunol.<\/i>, 15, 1335424.","DOI":"10.3389\/fimmu.2024.1335424"},{"key":"66","doi-asserted-by":"crossref","unstructured":"Sterner, R.C. &amp; Sterner, R.M.(2021) CAR-T cell therapy: current limitations and potential strategies. <i>Blood Cancer J.<\/i>, 11, 69.","DOI":"10.1038\/s41408-021-00459-7"},{"key":"67","doi-asserted-by":"crossref","unstructured":"Stoiber, S., Cadilha, B.L., Benmebarek, M.R., Lesch, S., Endres, S. &amp; Kobold, S.(2019) Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy. <i>Cells<\/i>, 8, 472.","DOI":"10.3390\/cells8050472"},{"key":"68","doi-asserted-by":"crossref","unstructured":"Syed, F., El Fakih, R., Alahmari, A.D., Osman Ali, A.S. &amp; Aljurf, M.(2022) Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors. <i>Hematol. Oncol. Stem Cell Ther.<\/i>, 15, 137-152.","DOI":"10.56875\/2589-0646.1048"},{"key":"69","doi-asserted-by":"crossref","unstructured":"Taub, D.D. (2008) Neuroendocrine interactions in the immune system. <i>Cell. Immunol.<\/i>, 252, 1-6.","DOI":"10.1016\/j.cellimm.2008.05.006"},{"key":"70","doi-asserted-by":"crossref","unstructured":"Wang, C., Wang, J., Che, S. &amp; Zhao, H.(2023) CAR-T cell therapy for hematological malignancies: History, status and promise. <i>Heliyon.<\/i>, 9, e21776.","DOI":"10.1016\/j.heliyon.2023.e21776"},{"key":"71","doi-asserted-by":"crossref","unstructured":"Weinkove, R., George, P., Dasyam, N. &amp; McLellan, A.D.(2019) Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations. <i>Clin. Transl. Immunology<\/i>, 8, e1049.","DOI":"10.1002\/cti2.1049"},{"key":"72","unstructured":"Writing Committee Members; Otto, C.M., Nishimura, R.A., Bonow, R.O., Carabello, B.A., Erwin, J.P. 3rd, Gentile, F., Jneid, H., Krieger, E.V., Mack, M., McLeod, C., O\u2019Gara, P.T., Rigolin, V.H., Sundt, T.M. 3rd, Thompson, A.,  et al. (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>J. Am. Coll. Cardiol.<\/i>, 77, e25-e197."},{"key":"73","doi-asserted-by":"crossref","unstructured":"Yang, W., Mixich, L., Boonstra, E. &amp; Cabral, H.(2023) Polymer-Based mRNA Delivery Strategies for Advanced Therapies. <i>Adv. Healthc. Mater.<\/i>, 12, e2202688.","DOI":"10.1002\/adhm.202202688"},{"key":"74","doi-asserted-by":"crossref","unstructured":"Yang, Z., Liu, Y. &amp; Zhao, H.(2024) CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases. <i>Life Sci.<\/i>, 344, 122556.","DOI":"10.1016\/j.lfs.2024.122556"},{"key":"75","doi-asserted-by":"crossref","unstructured":"Zaidi, Y., Aguilar, E.G., Troncoso, M., Ilatovskaya, D.V. &amp; DeLeon-Pennell, K.Y.(2021) Immune regulation of cardiac fibrosis post myocardial infarction. <i>Cell. Signal.<\/i>, 77, 109837.","DOI":"10.1016\/j.cellsig.2020.109837"},{"key":"76","doi-asserted-by":"crossref","unstructured":"Zhang, A., Sun, Y., Du, J., Dong, Y., Pang, H., Ma, L., Si, S., Zhang, Z., He, M., Yue, Y., Zhang, X., Zhao, W., Pi, J., Chang, M., Wang, Q.,  et al. (2021a) Reducing Hinge Flexibility of CAR-T Cells Prolongs Survival In Vivo With Low Cytokines Release. <i>Front. Immunol.<\/i>, 12, 724211.","DOI":"10.3389\/fimmu.2021.724211"},{"key":"77","doi-asserted-by":"crossref","unstructured":"Zhang, C., Wang, L., Zhang, Q., Shen, J., Huang, X., Wang, M., Huang, Y., Chen, J., Xu, Y., Zhao, W., Qi, Y., Li, Y., Ou, Y., Yang, Z. &amp; Qian, C.(2023) Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma. <i>Front. Immunol.<\/i>, 14, 1182409.","DOI":"10.3389\/fimmu.2023.1182409"},{"key":"78","doi-asserted-by":"crossref","unstructured":"Zhang, M., Jin, X., Sun, R., Xiong, X., Wang, J., Xie, D. &amp; Zhao, M.(2021b) Optimization of metabolism to improve efficacy during CAR-T cell manufacturing. <i>J. Transl. Med.<\/i>, 19, 499.","DOI":"10.1186\/s12967-021-03165-x"},{"key":"79","doi-asserted-by":"crossref","unstructured":"Zheng, D., Liwinski, T. &amp; Elinav, E.(2020) Interaction between microbiota and immunity in health and disease. <i>Cell Res.<\/i>, 30, 492-506.","DOI":"10.1038\/s41422-020-0332-7"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/2\/266_2024.J116\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:55:52Z","timestamp":1749873352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/266\/2\/266_2024.J116\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2024.j116","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2024.J116"}}